Identification of tyrosine kinase inhibitors that halt Plasmodium falciparum parasitemia

Although current malaria therapies inhibit pathways encoded in the parasite’s genome, we have looked for anti-malaria drugs that can target an erythrocyte component because development of drug resistance might be suppressed if the parasite cannot mutate the drug’s target. In search for such erythroc...

Descripción completa

Detalles Bibliográficos
Autores principales: Kesely, Kristina, Noomuna, Panae, Vieth, Michal, Hipskind, Philip, Haldar, Kasturi, Pantaleo, Antonella, Turrini, Francesco, Low, Philip S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7660480/
https://www.ncbi.nlm.nih.gov/pubmed/33180822
http://dx.doi.org/10.1371/journal.pone.0242372

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7660480/
https://www.ncbi.nlm.nih.gov/pubmed/33180822
http://dx.doi.org/10.1371/journal.pone.0242372

Ejemplares similares